52.29 USD
↗ 12.80 (32.40%)LIVE (AS OF 03:29 PM EDT)
Soleno Therapeutics, Inc. Common Stock
SLNONASDAQ • USD
Market: OPEN
Open?$52.31
High?$54.66
Low?$40.93
Prev. Close?$39.49
Volume?53.9M
Avg. Volume?1.8M
VWAP?$52.29
Rel. Volume?30.21x
Bid / Ask
Bid?$52.30 × 5.7K
Ask?$52.31 × 200
Spread?$0.01
Midpoint?$52.31
Valuation & Ratios
Market Cap?2.0B
Shares Out?51.6M
Float?49.4M
Float %?93.0%
P/E Ratio?99.57
P/B Ratio?4.53
EPS?$0.40
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?5.80Strong
Quick Ratio?5.55Strong
Cash Ratio?1.14Strong
Debt/Equity?0.11Low
ValuationRICHLY VALUED
Score39/100
P/E?99.6PRICEY▾
P/B?4.53FAIR▾
P/S?10.71HIGH▾
P/FCF?43.6PRICEY▾
EV/EBITDA?119.0HIGH▾
EV/Sales?10.60HIGH▾
Returns & Efficiency
ROE?4.6%WEAK▾
ROA?3.6%FAIR▾
Cash Flow & Enterprise
FCF?$46.7M
Enterprise Value?$2.0B
Related Companies
Loading...
News
Profile
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue. The company's reporting segment focused on the development and commercialization of its sole therapeutic product, VYKAT XR.
Address
100 MARINE PARKWAY, SUITE 400
REDWOOD CITY, CA 94065
Phone: 650-213-8444
REDWOOD CITY, CA 94065
Phone: 650-213-8444